IL1B and Alzheimer disease: On the other hand, studies indicate that microglia may contribute to the pathology of AD through the production of IL-1, activation of neuronal p38-MAPK, and synaptic and cytoskeletal alterations [107,108], which manages the aggregation of NTFs [8,19,22,36,118], which confirms their participation in AD, and thus become an important therapeutic target.